Michael Brawer, MD

Articles by Michael Brawer, MD

Dr. Brawer on the Results of the Prolaris Test for Patients Prostate Cancer

September 5th 2017

Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the results of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

Dr. Brawer on the Significance of the Prolaris Genetic Test for Prostate

ByMichael Brawer, MD

August 16th 2017

Michael Brawer, MD, vice president of medical affairs, Myriad Genetic Laboratories, discusses the significance of the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

Dr. Brawer on the Prolaris Genetic Test in Predicting Prostate Cancer Aggressiveness

ByMichael Brawer, MD

May 22nd 2017

Michael Brawer, MD, vice president of Medical Affairs, Myriad Genetic Laboratories, discusses the Prolaris genetic test in predicting prostate cancer aggressiveness in African-American men.

Dr. Brawer on Clinical Utility of CCP Test in Prostate Cancer

ByMichael Brawer, MD

May 17th 2015

Michael Brawer, MD, vice president of Medical Affairs, Myriad Genetic Laboratories, discusses the clinical utility of the cell cycle progression (CCP) test in personalizing prostate cancer treatment.